Home   »  TRADE TOPICS  »  Prescription Drugs  »  Trans Pacific Partnership

National Legislative Association on Prescription Drug Prices Resolution Opposing the Inclusion of a Pharmaceuticals Chapter in the Trans Pacific Partnership

January 24th, 2011

The resolution calls on the U.S. to halt the use of trade agreements to enact international disciplines on pharmaceutical pricing programs. It was passed at the winter meeting of the National Legislative Association on Prescription Drug Prices, an organization of state legislators that work on health issues.

The resolution specifically targets the ongoing negotiation of the Trans-Pacific Partnership (TPP), a plurilateral trade agreement among eight nations. To date, no negotiating text has been publicly released. But the branded drug lobby has requested the inclusion of a chapter in the agreement that would require countries to “appropriately recognize the value of patented medicines“ in public drug reimbursement programs and provide appeals for drug manufactures to challenge listing and reimbursement decisions of public health authorities.

Unless otherwise expressly stated, all original material of whatever nature created by the Forum on Democracy & Trade website is licensed under a Creative Commons License. Privacy Statement | Sitemap